Docstoc

Parkinson's Disease August 08

Document Sample
Parkinson's Disease August 08 Powered By Docstoc
					                                                                                             Library Network




                        Parkinson’s Disease

                                      August 08

                    Current Awareness Bulletin



Most of the following articles are available online via the NHS Scotland eLibrary.
Please use the links where provided and your ATHENS password. A complete list of
available online journals and registration for ATHENS can be found at
http://www.elib.scot.nhs.uk/


If you would like to request print copies of any of the articles please contact your
nearest library or visit the library website for further details.

                        http://www.nhsggc.org.uk/libraryservices

  Please note inter-library requests will only be done for South Glasgow NHS staff.
Please note, the articles you are accessing may be protected by copyright legislation, please
contact your librarian for a copyright declaration form if you are in any doubt. Or, consult the
Copyright Licensing Agency at http://www.cla.co.uk


If you have any questions regarding this or any other library services please contact
your librarian.

Compiled by C. Boulnois
Library Services Manager (South)
NHS Greater Glasgow & Clyde Library Network
Central Library
Southern General Hospital
1345 Govan Rd
G51 4TF
0141 201 2163
charlotte.boulnois@sgh.scot.nhs.uk


 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.
                                             References

1.   Akamatsu T, Fukuyama H, Kawamata T. The effects of visual, auditory, and mixed

     cues on choice reaction in parkinson's disease. J Neurol Sci. 2008; 269(1-2):118-125.


2.   Androulidakis AG, Mazzone P, Litvak V, et al. Oscillatory activity in the

     pedunculopontine area of patients with parkinson's disease. Exp Neurol. 2008;

     211(1):59-66.


3.   Asanuma M, Miyazaki I. Nonsteroidal anti-inflammatory drugs in experimental

     parkinsonian models and parkinson's disease. Curr Pharm Des. 2008; 14(14):1428-

     1434.


4.   Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F. The thrill of reckless

     driving in patients with parkinson's disease: An additional behavioural phenomenon in

     dopamine dysregulation syndrome?. Parkinsonism Relat Disord. 2008; 14(3):257-

     258.


5.   Bartels AL, Willemsen ATM, Kortekaas R, et al. Decreased blood-brain barrier P-

     glycoprotein function in the progression of parkinson's disease, PSP and MSA. J Neural

     Transm. 2008; 115(7):1001-1009.


6.   Berg D, Riederer P, Gerlach M. Contribution of disturbed iron metabolism to the

     pathogenesis of parkinson's disease. Future Neurology. 2008; 3(4):447-461.


7.   Bick RJ, Poindexter BJ, Kott MM, et al. Cytokines disrupt intracellular patterns of

     parkinson's disease-associated proteins alpha-synuclein, tau and ubiquitin in cultured

     glial cells. Brain Res. 2008; 1217(C):203-212.


8.   Blomstedt P, Hariz MI, Lees A, et al. Acute severe depression induced by

     intraoperative stimulation of the substantia nigra: A case report. Parkinsonism Relat

     Disord. 2008; 14(3):253-256.


9.   Bohnen NI, Studenski SA, Constantine GM, Moore RY. Diagnostic performance of

     clinical motor and non-motor tests of parkinson disease: A matched case-control

     study. European Journal of Neurology. 2008; 15(7):685-691.



 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.
10.    Bonneville F, Bloch F, Kurys E, et al. Camptocormia and parkinson's disease: MR

      imaging. Eur Radiol. 2008; 18(8):1710-1719.


11.    Borg C, Anterion CT, Vioux H, Poujois A, Laurent B. Public events and flashbulb

      memories in parkinson's disease. Behav Neurol. 2008; 19(1-2):49-52.


12.    Burgener SC, Berger B. Measuring perceived stigma in persons with progressive

      neurological disease: Alzheimer's dementia and parkinson's disease. Dementia. 2008;

      7(1):31-53.


13.    Camicioli RM, Wieler M, de Frias CM, Martin WRW. Early, untreated parkinson's

      disease patients show reaction time variability. Neurosci Lett. 2008; 441(1):77-80.


14.    Castelli L, Perozzo P, Caglio M, et al. Does subthalamic stimulation induce

      personality modifications in parkinson's disease? A rorschach test explorative study.

      Acta Neurol Belg. 2008; 108(1):5-8.


15.    Chaudhuri KR. Health-related quality of life in asian and other ethnic groups with

      parkinson's disease. European Journal of Neurology. 2008; 15(7):642.


16.    Cooper MK, Brock DG, McDaniel CM. Interaction between levodopa and enteral

      nutrition. Ann Pharmacother. 2008; 42(3):439-442.


17.    Corti O, Brice A. Of parkin and parkinson's: Light and dark sides of a multifaceted

      E3 ubiquitin-protein ligase. Drug Discovery Today: Disease Mechanisms. 2007;

      4(2):121-127.


18.    Costa A, Peppe A, Brusa L, Caltagirone C, Gatto I, Carlesimo GA. Dopaminergic

      modulation of prospective memory in parkinson's disease. Behav Neurol. 2008; 19(1-

      2):45-48.


19.    Cropley VL, Fujita M, Bara-Jimenez W, et al. Pre- and post-synaptic dopamine

      imaging and its relation with frontostriatal cognitive function in parkinson disease:

      PET studies with [11C]NNC 112 and [18F]FDOPA. Psychiatry Research - Neuroimaging.

      2008; 163(2):171-182.




 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.
20.    Damianakis T, Climans R, Marziali E. Social workers' experiences of virtual

      psychotherapeutic caregivers groups for alzheimer's, parkinson's, stroke,

      frontotemporal dementia, and traumatic brain injury. Soc Work Groups. 2008;

      31(2):99-116.


21.    Damier P, Viallet F, Ziegler M, Bourdeix I, Rerat K. Levodopa/DDCI and entacapone

      is the preferred treatment for parkinson's disease patients with motor fluctuations in

      routine practice: A retrospective, observational analysis of a large french cohort.

      European Journal of Neurology. 2008; 15(7):643-648.


22.    De Marco EV, Tarantino P, Rocca FE, et al. Alpha-synuclein promoter haplotypes and

      dementia in parkinson's disease. Am J Med Genet B Neuropsychiatr Genet. 2008;

      147(3):403-407.


23.    DelleDonne A, Klos KJ, Fujishiro H, et al. Incidental lewy body disease and

      preclinical parkinson disease. Archives of Neurology. 2008; 65(8):1074-1080.


24.    Dickson DW, Fujishiro H, DelleDonne A, et al. Evidence that incidental lewy body

      disease is pre-symptomatic parkinson's disease. Acta Neuropathol (Berl). 2008;

      115(4):437-444.


25.    Drapier D, Peron J, Leray E, et al. Emotion recognition impairment and apathy after

      subthalamic nucleus stimulation in parkinson's disease have separate neural

      substrates. Neuropsychologia. 2008; 46(11):2796-2801.


26.    Drechsel DA, Patel M. Role of reactive oxygen species in the neurotoxicity of

      environmental agents implicated in parkinson's disease. Free Radic Biol Med. 2008;

      44(11):1873-1886.


27.    Engelender S. Ubiquitination of alpha-synuclein and autophagy in parkinson's

      disease. Autophagy. 2008; 4(3):372-374.


28.    Espay AJ. Reversible parkinsonism and ataxia associated with high-dose octreotide.

      Neurology. 2008; 70(24 Part 1):2345-2346.




 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.
29.    Etminan M, Carleton BC, Samii A. Non-steroidal anti-inflammatory drug use and the

      risk of parkinson disease: A retrospective cohort study. J Clin Neurosci. 2008;

      15(5):576-577.


30.    Feng T, Wang Y, Ouyang Q, et al. Comparison of cerebral glucose metabolism

      between multiple system atrophy parkinsonian type and parkinson's disease. Neurol

      Res. 2008; 30(4):377-382.


31.    Fisher B.E. Wu A.D. Salem G.J. Song J. Lin C.-H.(J.) Yip J. Cen S. Gordon J.

      Jakowec M. Petzinger G. The effect of exercise training in improving motor

      performance and corticomotor excitability in people with early parkinson's disease.

      Arch Phys Med Rehabil. 2008; 89(7):1221-1229.


32.    Florin E, Reck C, Burghaus L, et al. Ten hertz thalamus stiumulation increases

      tremor activity in the subthalmic nucleus in a patient with parkinson's disease. Clinical

      Neurophysiology. 2008; 119(9):2098-2103.


33.    Foster ER, Black KJ, AntenorDorsey JA, Perlmutter JS, Hershey T. Motor asymmetry

      and substantia nigra volume are related to spatial delayed response performance in

      parkinson disease. Brain Cognit. 2008; 67(1):1-10.


34.    Frisina PG, Tenenbaum HR, Borod JC, Foldi NS. The effects of antidepressants in

      parkinson's disease: A meta-analysis. Int J Neurosci. 2008; 118(5):667-682.


35.    Gellein K, Syversen T, Steinnes E, et al. Trace elements in serum from patients with

      parkinson's disease - a prospective case-control study. the nord-trondelag health

      study (HUNT). Brain Res. 2008; 1219(C):111-115.


36.    Greggio E, Zambrano I, Kaganovich A, et al. The parkinson disease-associated

      leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular

      autophosphorylation. J Biol Chem. 2008; 283(24):16906-16914.


37.    Halliday G. Clarifying the pathological progression of parkinson's disease. Acta

      Neuropathol (Berl). 2008; 115(4):377-378.




 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.
38.    Halliday G, Hely M, Reid W, Morris J. The progression of pathology in longitudinally

      followed patients with parkinson's disease. Acta Neuropathol (Berl). 2008;

      115(4):409-415.


39.    Haunton V, Lo N. Non-motor symptoms in parkinson's disease: A neglected area.

      Geriatr Med. 2008; 38(Supplement 2):7-15.


40.    Havlikova E, Rosenberger J, Nagyova I, et al. Clinical and psychosocial factors

      associated with fatigue in patients with parkinson's disease. Parkinsonism Relat

      Disord. 2008; 14(3):187-192.


41.    Hellmann MA, Sabach T, Melamed E, Djaldetti R. Effect of subcutaneous

      apomorphine on tremor in idiopathic parkinson's disease. Biomed Pharmacother.

      2008; 62(4):250-252.


42.    Holford N, Nutt JG. Disease progression, drug action and parkinson's disease: Why

      time cannot be ignored. Eur J Clin Pharmacol. 2008; 64(2):207-216.


43.    Hurtado-Lorenzo A, Anand VS. Heat shock protein 90 modulates LRRK2 stability:

      Potential implications for parkinson's disease treatment. J Neurosci. 2008;

      28(27):6757-6759.


44.    Ishihara T, Ozawa T, Igarashi S, et al. Atypical parkinsonism in distal myopathy with

      rimmed vacuoles. Mov Disord. 2008; 23(6):912-915.


45.    Iwamoto J, Matsumoto H, Takeda T. Efficacy of risedronate against hip fracture in

      patients with neurological diseases: A meta-analysis of randomized controlled trials.

      Curr Med Res Opin. 2008; 24(5):1379-1384.


46.    Jones DG, Galvin KA. Neural grafting in parkinson's disease: Scientific and ethical

      pitfalls on the road from basic science to clinical reality. Research Communications in

      Biological Psychology, Psychiatry and Neurosciences. 2006; 30-31(pp 75-101):ate of

      Pubaton: 2005.




 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.
47.    Kamanli A, Ardicoglu O, Ozgocmen S, Yoldas TK. Bone mineral density in patients

      with parkinson's disease. Aging - Clinical and Experimental Research. 2008;

      20(3):277-279.


48.    Koch G, Costa A, Brusa L, et al. Impaired reproduction of second but not millisecond

      time intervals in parkinson's disease. Neuropsychologia. 2008; 46(5):1305-1313.


49.    Kovacs N, Nagy F, Balas I, Komoly S, Janszky J. Oxcarbazepine may induce

      psychotic symptoms in parkinson's disease. Epilepsy Behav. 2008; 12(3):492-493.


50.    Kuncel AM, Cooper SE, Grill WM. A method to estimate the spatial extent of

      activation in thalamic deep brain stimulation. Clinical Neurophysiology. 2008;

      119(9):2148-2158.


51.    Lanni C, Racchi M, Mazzini G, et al. Conformationally altered p53: A novel

      alzheimer's disease marker?. Mol Psychiatry. 2008; 13(6):641-647.


52.    Lashley T, Holton JL, Gray E, et al. Cortical alpha-synuclein load is associated with

      amyloid-beta plaque burden in a subset of parkinson's disease patients. Acta

      Neuropathol (Berl). 2008; 115(4):417-425.


53.    Lees AJ. Evidence-based efficacy comparison of tolcapone and entacapone as

      adjunctive therapy in parkinson's disease. CNS Neuroscience and Therapeutics. 2008;

      14(1):83-93.


54.    Lima MMS, Reksidler AB, Vital MABF. The dopaminergic dilema: Sleep or wake?

      implications in parkinson's disease. Bioscience Hypotheses. 2008; 1(1):9-13.


55.    Lin S, Chen T, Lin S, et al. Subthalmic deep brain stimulation after anesthetic

      inhalation in parkinson disease: A preliminary study. Journal of Neurosurgery. 2008;

      109(2):238-244.


56.    Llumiguano C, Kovacs N, Usprung Z, Schwarcz A, Doczi TP, Balas I. 1H-MRS

      experiences after bilateral DBS of the STN in parkinson's disease. Parkinsonism Relat

      Disord. 2008; 14(3):229-232.




 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.
57.    Lu YW, Tan EK. Molecular biology changes associated with LRRK2 mutations in

      parkinson's disease. J Neurosci Res. 2008; 86(9):1895-1901.


58.    Madigan EJ. A 77-year-old man with parkinson's disease and hyperthermia. J Emerg

      Nurs. 2008; 34(3):229-230.


59.    Mancini M, Rocchi L, Horak FB, Chiari L. Effects of parkinson's disease and levodopa

      on functional limits of stability. Clin Biomech. 2008; 23(4):450-458.


60.    Marina MB, Sani A, Hamzaini AH, Hamidon BB. Ultrasound-guided botulinum toxin A

      injection: An alternative treatment for dribbling. J Laryngol Otol. 2008; 122(6):609-

      614.


61.    Markopoulou K, Dickson DW, McComb RD, et al. Clinical, neuropathological and

      genotypic variability in SNCA A53T familial parkinson's disease. Acta Neuropathol.

      2008; 116(1):25-35.


62.    Masaoka Y, Satoh H, Kawamura M, Homma I. Respiratory responses to olfactory

      stimuli in parkinson's disease. Respir Physiolo Neurobiol. 2008; 161(2):136-141.


63.    Moazami-Goudarzi M, Sarnthein J, Michels L, Moukhtieva R, Jeanmonod D.

      Enhanced frontal low and high frequency power and synchronization in the resting

      EEG of parkinsonian patients. Neuroimage. 2008; 41(3):985-997.


64.    Moller JC, Rissling I, Mylius V, Hoft C, Eggert KM, Oertel WH. The prevalence of the

      G2019S and R1441C/G/H mutations in LRRK2 in german patients with parkinson's

      disease. European Journal of Neurology. 2008; 15(7):743-745.


65.    Moller JC, Rissling I, Mylius V, Hoft C, Eggert KM, Oertel WH. The prevalence of the

      G2019S and R1441C/G/H mutations in LRRK2 in german patients with parkinson's

      disease. Eur J Neurol. 2008; 15(7):743-745.


66.    Monahan AJ, Warren M, Carvey PM. Neuroinflammation and peripheral immune

      infiltration in parkinson's disease: An autoimmune hypothesis. Cell Transplant. 2008;

      17(4):363-372.




 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.
67.    Monetta L, Grindrod CM, Pell MD. Effects of working memory capacity on inference

      generation during story comprehension in adults with parkinson's disease. Journal of

      Neurolinguistics. 2008; 21(5):400-417.


68.    Moran LB, Hickey L, Michael GJ, et al. Neuronal pentraxin II is highly upregulated in

      parkinson's disease and a novel component of lewy bodies. Acta Neuropathol (Berl).

      2008; 115(4):471-478.


69.    Moreau C, Defebvre L, Destee A, et al. STN-DBS frequency effects on freezing of

      gait in advanced parkinson disease. Neurology. 2008; 71(2):80-84.


70.    Mori F, Tanji K, Zhang H, Kakita A, Takahashi H, Wakabayashi K. Alpha-synuclein

      pathology in the neostriatum in parkinson's disease. Acta Neuropathol (Berl). 2008;

      115(4):453-459.


71.    Morita Y, Osaki Y, Doi Y. Transcranial magnetic stimulation for differntial diagnostics

      in patients with parkinsonism. Acta Neurologica Scandinavica. 2008; 1183(159):163.


72.    Moriwaki Y, Kim YJ, Ido Y, et al. L347P PINK1 mutant that fails to bind to

      Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner.

      Neurosci Res. 2008; 61(1):43-48.


73.    Mrakic-Sposta S, Marceglia S, Egidi M, et al. Extracellular spike microrecordings

      from the subthalamic area in parkinson's disease. J Clin Neurosci. 2008; 15(5):559-

      567.


74.    Natale G, Pasquali L, Ruggieri S, Paparelli A, Fornai F. Parkinson's disease and the

      gut: A well known clinical association in need of an effective cure and explanation.

      Neurogastroenterology and Motility. 2008; 20(7):741-749.


75.    Nobrega AC, Rodrigues B, Torres AC, Scarpel RD, Neves CA, Melo A. Is drooling

      secondary to a swallowing disorder in patients with parkinson's disease?.

      Parkinsonism Relat Disord. 2008; 14(3):243-245.


76.    Okubadejo NU. An analysis of genetic studies of parkinson's disease in africa.

      Parkinsonism Relat Disord. 2008; 14(3):177-182.

 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.
77.    Onla-Or S, Winstein CJ. Determining the optimal challenge point for motor skill

      learning in adults with moderately severe parkinson's disease. Neurorehabil Neural

      Repair. 2008; 22(4):385-395.


78.    Onofrj M, Bonanni L, Thomas A. An expert opinion on safinamide in parkinson's

      disease. Expert Opin Investig Drugs. 2008; 17(7):1115-1125.


79.    Pan T, Kondo S, Le W, Jankovic J. The role of autophagy-lysome pathway in

      neurodegeneration associated with parkinson's disease. Brain. 2008; 131(8):1969-

      1978.


80.    Papapetropoulos S, Katzen H, Schrag A, et al. A questionnaire-based (UM-PDHQ)

      study of hallucinations in parkinson's disease. BMC Neurol. 2008; 8:21.


81.    Pchelina SN, Yakimovskii AF, Emelyanov AK, Ivanova ON, Schwarzman AL,

      Singleton AB. Screening for LRRK2 mutations in patients with parkinson's disease in

      russia: Identification of a novel LRRK2 variant. European Journal of Neurology. 2008;

      15(7):692-696.


82.    Pchelina SN, Yakimovskii AF, Emelyanov AK, Ivanova ON, Schwarzman AL,

      Singleton AB. Screening for LRRK2 mutations in patients with parkinson's disease in

      russia: Identification of a novel LRRK2 variant. Eur J Neurol. 2008; 15(7):692-696.


83.    Pedersen KF, Larsen JP, Aarsland D. Validation of the unified parkinson's disease

      rating scale (UPDRS) section I as a screening and diagnostic instrument for apathy in

      patients with parkinson's disease. Parkinsonism Relat Disord. 2008; 14(3):183-186.


84.    Pham DQ, Nogid A. Rotigotine transdermal system for the treatment of parkinson's

      disease. Clin Ther. 2008; 30(5):813-824.


85.    Poliakoff E, Smith-Spark JH. Everyday cognitive failures and memory problems in

      parkinson's patients without dementia. Brain Cogn. 2008; 67(3):340-350.


86.    Ponsen MM, Daffertshofer A, Wolters EC, Beek PJ, Berendse HW. Impairment of

      complex upper limb motor function in de novo parkinson's disease. Parkinsonism

      Relat Disord. 2008; 14(3):199-204.

 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.
87.    Post B, Speelman JD, De Haan RJ. Clinical heterogeneity in newly diagnosed

      parkinson's disease. J Neurol. 2008; 255(5):716-722.


88.    Post B, Speelman JD, de Haan RJ, CARPA-study g. Clinical heterogeneity in newly

      diagnosed parkinson's disease. J Neurol. 2008; 255(5):716-722.


89.    Prestel J, Gempel K, Hauser TK, et al. Clinical and molecular characterisation of a

      parkinson family with a novel PINK1 mutation. J Neurol. 2008; 255(5):643-648.


90.    Reichmann H, Schupbach WMM. Pramipexole in the management of parkinson's

      disease. Aging Health. 2008; 4(3):225-235.


91.    Romigi A, Placidi F, Peppe A, et al. Pedunculopontine nucleus stimulation influences

      REM sleep in parkinson's disease. European Journal of Neurology. 2008; 15(7):e64-

      e65.


92.    Ross OA, Wu Y, Lee M, et al. Analysis of Lrrk2 R1628P as a risk factor for

      parkinson's disease. Annals of Neurology. 2008; 64(1):88-92.


93.    Rowe JB, Hughes L, Ghosh BCP, et al. Prkinson's disease and dopaminergic therapy

      - differential effects on movement, reward and cognition. Brain. 2008; 131(8):2094-

      2105.


94.    Rudow G, O'Brien R, Savonenko AV, et al. Morphometry of the human substantia

      nigra in ageing and parkinson's disease. Acta Neuropathol (Berl). 2008; 115(4):461-

      470.


95.    Saaksjarvi K, Knekt P, Rissanen H, Laaksonen MA, Reunanen A, Mannisto S.

      Prospective study of coffee consumption and risk of parkinson's disease. Eur J Clin

      Nutr. 2008; 62(7):908-915.


96.    Salzman C, Jeste DV, Meyer RE, et al. Elderly patients with dementia-related

      symptoms of severe agitation and aggression: Consensus statement on treatment

      options, clinical trials methodology, and policy. J Clin Psychiatry. 2008; 69(6):889-

      898.




 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.
97.     Samantaray S, Ray SK, Banik NL. Calpain as a potential therapeutic target in

       parkinson's disease. CNS and Neurological Disorders - Drug Targets. 2008; 7(3):305-

       312.


98.     Serrano-Duenas M, Soledad Serrano M. Concurrent validation of the 21-item and 6-

       item hamilton depression rating scale versus the DSM-IV diagnostic criteria to assess

       depression in patients with parkinson's disease: An exploratory analysis. Parkinsonism

       Relat Disord. 2008; 14(3):233-238.


99.     Simola N, Morelli M, Pinna A. Adenosine A2A receptor antagonists and parkinson's

       disease: State of the art and future directions. Curr Pharm Des. 2008; 14(15):1475-

       1489.


100.      Simonetto M, Ferigo L, Zanet L, et al. Acute akinesia, an unusual complication in

       parkinson's disease: A case report. Neurological Sciences. 2008; 29(3):181-183.


101.      Singh M, Khan AJ, Shah PP, Shukla R, Khanna VK, Parmar D. Polymorphism in

       environment responsive genes and association with parkinson disease. Mol Cell

       Biochem. 2008; 312(1-2):131-138.


102.      Solimeo S. Sex and gender in older adults' experience of parkinson's disease. J

       Gerontol B Psychol Sci Soc Sci. 2008; 63B(1):S42-8.


103.      Soysal A, Sobe I, Atay T, Sen A, Arpaci B. Effect of therapy on motor cortical

       excitability in parkinson's disease. Canadian Journal of Neurological Sciences. 2008;

       35(2):166-172.


104.      Stacy MA, Murphy JM, Greeley DR, et al. Parkinsonism Relat Disord. 2008;

       14(3):205-212.


105.      Starr PA, Kang GA, Heath S, Shimamoto S, Turner RS. Pallidal neuronal discharge

       in huntington's disease: Support for selective loss of striatal cells originating the

       indirect pathway. Exp Neurol. 2008; 211(1):227-233.




 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.
106.      Sun DA, Yu H, Spooner J, et al. Postmortem analysis following 71 months of deep

       brain stimulation of the subthalmic nucleus for parkinson disease: Case report.

       Journal of Neurosurgery. 2008; 109(2):325-329.


107.      Suzuki K, Miyamoto T, Miyamoto M, Nishibayashi M, Hirata K. Daytime sleepiness

       in parkinson's disease patient worsened by changing medication between same types

       of dopamine agonists. Sleep and Biological Rhythms. 2008; 6(3):180-182.


108.      Tabbal SD, Ushe M, Mink JW, et al. Unilateral subthalamic nucleus stimulation has

       a measurable ipsilateral effect on rigidity and bradykinesia in parkinson disease. Exp

       Neurol. 2008; 211(1):234-242.


109.      Tessari I, Bisaglia M, Valle F, et al. The reaction of alpha-synuclein with tyrosinase:

       Possible implications for parkinson disease. J Biol Chem. 2008; 283(24):16808-

       16817.


110.      Tinazzi M, Del Vesco C, Defazio G, et al. Abnormal processing of the nociceptive

       input in parkinson's disease: A study with CO2 laser evoked potentials. Pain. 2008;

       136(1-2):117-124.


111.      Tobin JE, Latourelle JC, Lew MF, et al. Haplotypes and gene expression implicate

       the MAPT region for parkinson disease: The GenePD study. Neurology. 2008;

       71(1):28-34.


112.      Torta DM, Castelli L. Reward pathways in parkinson's disease: Clinical and

       theoretical implications. Psychiatry Clin Neurosci. 2008; 62(2):203-213.


113.      Turner MR, Matthews L, Ebers GC. Teaching video NeuroImage: The "fonzarelli"

       sign: Focal thumb dystonia as an early manifestation of parkinson disease. Neurology.

       2008; 71(6):e11.


114.      Valeikiene V, Ceremnych J, Alekna V, Juozulynas A. Differences in WHOQOL-100

       domain scores in parkinson's disease and osteoarthritis. Med Sci Monit. 2008;

       14(4):R221-7.




Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                          current articles and not intended to be exhaustive.
115.      van Beilen M, Portman AT, Kiers HA, et al. Striatal FDOPA uptake and cognition in

       advanced non-demented parkinson's disease: A clinical and FDOPA-PET study.

       Parkinsonism Relat Disord. 2008; 14(3):224-228.


116.      Velez Feijo A, Rieder CRM, Chaves MLF. Did depressive symptoms affect

       recognition of emotional prosody in parkinson's disease?. Neuropsychiatric Disease

       and Treatment. 2008; 4(3):669-674.


117.      Vilarino-Guell C, Soto AI, Young JE, et al. Susceptibility genes for restless legs

       syndrome are not associated with parkinson disease. Neurology. 2008; 71(3):222-

       223.


118.      Ward RJ, Lallemand F, de Witte P, Dexter DT. Neurochemical pathways involved in

       the protective effects of nicotine and ethanol in preventing the development of

       parkinson's disease: Potential targets for the development of new therapeutic agents.

       Prog Neurobiol. 2008; 85(2):135-147.


119.      Wearden JH, Smith-Spark JH, Cousins R, Edelstyn NM, Cody FW, O'Boyle DJ.

       Stimulus timing by people with parkinson's disease. Brain Cogn. 2008; 67(3):264-

       279.


120.      Weiner WJ. Early diagnosis of parkinson's disease and initiation of treatment.

       Reviews in Neurological Diseases. 2008; 5(2):47-55.


121.      Wilkinson L, Lagnado DA, Quallo M, Jahanshahi M. The effect of feedback on non-

       motor probabilistic classification learning in parkinson's disease. Neuropsychologia.

       2008; 46(11):2683-2695.


122.      Wilson RS, Arnold SE, Buchman AS, Tang Y, Bennett DA. Odor identification and

       progression of parkinsonian signs in older persons. Exp Aging Res. 2008; 34(3):173-

       187.


123.      Wolters E, Lees AJ, Volkmann J, van Laar T, Hovestadt A. Managing parkinson's

       disease with continuous dopaminergic stimulation. CNS Spectr. 2008; 13(4 Suppl

       7):1-14.


Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                          current articles and not intended to be exhaustive.
124.      Wu G, Yan B, Wang X, et al. Decreased activities of lysosomal acid alpha-D-

       galactosidase A in the leukocytes of sporadic parkinson's disease. J Neurol Sci. 2008;

       271(1-2):168-173.


125.      Xiromerisiou G, Hadjigeorgiou GM, Papadimitriou A, Katsarogiannis E, Gourbali V,

       Singleton AB. Association between AKT1 gene and parkinson's disease: A protective

       haplotype. Neurosci Lett. 2008; 436(2):232-234.


126.      Yenice O, Onal S, Midi I, Ozcan E, Temel A, I-Gunal D. Visual field analysis in

       patients with parkinson's disease. Parkinsonism Relat Disord. 2008; 14(3):193-198.


127.      York MK, Dulay M, Macias A, et al. Cognitive declines following bilateral

       subthalamic nucleus deep brain stimulation for the treatment of parkinson's disease.

       Journal of Neurology, Neurosurgery and Psychiatry. 2008; 79(7):789-795.


128.      Yunusova Y, Weismer G, Westbury JR, Lindstrom MJ. Articulator movements

       during vowels in speakers with dysarthria and healthy controls. Journal of Speech,

       Language, and Hearing Research. 2008; 51(3):596-611.


129.      Yust-Katz S, Sthneer S, Melamed E, Djaldetti R. Long-term parkinson's disease--

       time for optimism. Biomed Pharmacother. 2008; 62(4):233-235.


130.      Zeevalk GD, Razmpour R, Bernard LP. Glutathione and parkinson's disease: Is this

       the elephant in the room?. Biomed Pharmacother. 2008; 62(4):236-249.


131.      Zhao YJ, Tan LC, Lau PN, Au WL, Li SC, Luo N. Factors affecting health-related

       quality of life amongst asian patients with parkinson's disease. Eur J Neurol. 2008;

       15(7):737-742.




Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                          current articles and not intended to be exhaustive.
If you would like to receive additional bulletin, please tick the bulletins you would like to receive,
ensure your name and address are on the front cover and return to the library address given
overleaf.


   A&E                                                          Healthcare Associated Infection
   Allied Health Professionals                                  Healthy Heart
   Alzheimer’s disease                                          IT
   Ambulatory care                                              Lung Cancer
   Anaesthesia                                                  Medicine for the Elderly
   Asthma                                                       Multiple Sclerosis
   Burns/Dermatology/Plastics                                   Neonatal Nursing and Midwifery
   Cancer: Pain                                                 New Books
   Cancer Supportive Care                                       New Books (all sites & Nursing)
   Chaplain                                                     New Nurse
   Child Protection                                             Nutrition
   Clinical Governance                                          Orthopaedics
   Community Child Health                                       Paediatric Anaesthesia & Pain
   Community Nursing                                            Paediatric Oncology Nursing
   Complaints                                                   Paediatric Physiotherapy
   Coronary Intensive and High Dependency Care                  Paediatric Respiratory Medicine
   Corporate Services                                           Parkinson’s disease
   Day surgery                                                  Pharmacy
   Dental Care Professionals                                    Prevention & Treatment of Alcohol &
                                                             Drug Abuse (Nursing)
   Dentistry                                                    Primary Care Mental Health
   Digestive Diseases                                           Rheumatology
   Elderly Care Bulletin (Nursing)                              Sarcoma
   Epilepsy                                                     School nurses
   Guidelines                                                   Speech and Language Therapy
   Gynaecologic Oncology                                        Spinal Injuries
   Head Injury                                                  Stroke (North Glasgow)
   Health Promotion                                             Stroke (South Glasgow)
                                                                Training, education and Management
                                                             (Nursing)




                            How to Access Electronic Articles

Many of the articles in this bulletin will be available online at the NHS Scotland eLibrary

    1.   Go to the NHS Scotland eLibrary http://www.elib.scot.nhs.uk
    2.   Click on Journals
    3.   Type in the journal title and click search.
    4.   Click on the appropriate title, then select the supplier you wish to use.
    5.   Put in your Athens password at the “Athens login” link.
    6.   Select the correct year, volume, issue and page number for the article you
         want.

Please note, the articles you are accessing may be protected by copyright legislation, please
contact your librarian for a copyright declaration form if you are in any doubt. Or, consult the
Copyright Licensing Agency at http://www.cla.co.uk


If you have any questions regarding this or any other library services please contact
your librarian.

Compiled by C. Boulnois
Library Services Manager
NHS Greater Glasgow & Clyde Library Network
Central Library
Southern General Hospital
1345 Govan Rd
Glasgow
G51 4TF
0141 201 2163
charlotte.boulnois@sgh.scot.nhs.uk




 Current Awareness Bulletins provided by NHS Greater Glasgow & Clyde Library Network are a selection of
                           current articles and not intended to be exhaustive.

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:11
posted:11/6/2012
language:Unknown
pages:16